AK112, Cadonilimab, nab-paclitaxel, gemcitabine
AK112-210
Phase 2 small_molecule active
Quick answer
AK112, Cadonilimab, nab-paclitaxel, gemcitabine for Metastatic Pancreatic Ductal Adenocarcinoma is a Phase 2 program (small_molecule) at Akeso with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Akeso
- Indication
- Metastatic Pancreatic Ductal Adenocarcinoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active